{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:26:22Z","timestamp":1786112782480,"version":"build-2736575974"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"the National University-Industry-Research Innovation Fund of China","award":["2024GR046"],"award-info":[{"award-number":["2024GR046"]}]},{"name":"Weifang Science and Technology Development Plan","award":["2023YX039"],"award-info":[{"award-number":["2023YX039"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,8]]},"abstract":"<jats:p>\n                    Hepatitis B virus (HBV) infection represents a significant global health burden, with over 2 billion people affected worldwide and an increased risk of liver-related complications and mortality. Simple and effective prognostic tools are needed to stratify mortality risk in this population. This study aimed to evaluate the prognostic value of the advanced lung cancer inflammation index (ALI) for long-term mortality risk in individuals with HBV infection. This cohort study included participants with evidence of prior or current HBV infection from the National Health and Nutrition Examination Survey (1999\u20132018). The ALI was calculated as (body mass index\u2005\u00d7\u2005serum albumin)\/neutrophil-to-lymphocyte ratio. Mortality data were linked to the National Death Index. Weighted multivariable Cox proportional hazards models and restricted cubic splines were used to assess associations between ALI and all-cause and cancer mortality, adjusting for demographic, clinical, and laboratory covariates. Among 3208 participants (representing 9194,530 US adults), 588 all-cause and 127 cancer deaths occurred. After full adjustment, a higher ALI was independently associated with a lower risk of all-cause mortality (highest vs lowest quartile: hazard ratio [HR], 0.56; 95% CI, 0.40\u20130.79;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    for trend\u2005&lt;\u2005.001). A significant L-shaped nonlinear relationship was identified, with an inflection point at ALI\u2005=\u2005108.34. Below this threshold, each 10-unit increase in ALI was associated with a 9.0% reduction in all-cause mortality risk (HR, 0.910; 95% CI, 0.870\u20130.953;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). In contrast, ALI was not significantly associated with cancer mortality after multivariable adjustment (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    for trend\u2005=\u2005.22). Sensitivity and subgroup analyses confirmed the robustness of the primary findings for all-cause mortality. In summary, in this nationally representative cohort of HBV-infected individuals, a lower ALI was independently associated with an increased risk of all-cause mortality in an L-shaped nonlinear pattern, with a threshold near 108. This readily accessible index may serve as a practical tool for risk stratification in this population.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000048403","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:01:59Z","timestamp":1778745719000},"page":"e48403","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The advanced lung cancer inflammation index (ALI) for risk stratification of all-cause mortality in individuals with hepatitis B virus infection: A cohort study based on NHANES"],"prefix":"10.1097","volume":"105","author":[{"given":"Wenwen","family":"Fan","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Affiliated Hospital of Shandong Second Medical University, Weifang, Shandong Province, China"},{"name":"Department of Medical Laboratory Science, Shandong Second Medical University, Weifang, Shandong Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxiao","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Affiliated Hospital of Shandong Second Medical University, Weifang, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjuan","family":"Qiao","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Science, Shandong Second Medical University, Weifang, Shandong Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8050-2341","authenticated-orcid":false,"given":"Chunqiang","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Affiliated Hospital of Shandong Second Medical University, Weifang, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260805","doi-asserted-by":"crossref","first-page":"18035","DOI":"10.1038\/nrdp.2018.35","article-title":"Hepatitis B virus infection.","volume":"4","author":"Yuen","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20260805","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S2468-1253(22)00386-7","article-title":"Global reporting of progress towards elimination of hepatitis B and hepatitis C.","volume":"8","author":"Cui","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R3-20260805","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S2468-1253(18)30002-5","article-title":"Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis.","volume":"3","author":"Mucke","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R4-20260805","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/MCG.0b013e3182972254","article-title":"Past exposure to hepatitis B: a risk factor for increase in mortality?","volume":"48","author":"Jinjuvadia","year":"2014","journal-title":"J Clin Gastroenterol"},{"key":"R5-20260805","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1007\/s40121-022-00680-2","article-title":"Prevalence of cirrhosis\/advanced fibrosis among HBsAg-Negative and HBcAb-positive US adults: a nationwide population-based study.","volume":"11","author":"Huang","year":"2022","journal-title":"Infect Dis Ther"},{"key":"R6-20260805","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/17474124.2018.1463158","article-title":"The role of neutrophil to lymphocyte ratio for the assessment of liver fibrosis and cirrhosis: a systematic review.","volume":"12","author":"Peng","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R7-20260805","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12072-015-9665-6","article-title":"Albumin in chronic liver disease: structure, functions and therapeutic implications.","volume":"10","author":"Spinella","year":"2016","journal-title":"Hepatol Int"},{"key":"R8-20260805","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3748\/wjg.v30.i10.1295","article-title":"Overview of the immunological mechanisms in hepatitis B virus reactivation: implications for disease progression and management strategies.","volume":"30","author":"Ma","year":"2024","journal-title":"World J Gastroenterol"},{"key":"R9-20260805","doi-asserted-by":"crossref","first-page":"102639","DOI":"10.1016\/j.pmedr.2024.102639","article-title":"Albumin-bilirubin score as a predictor of all-cause mortality in patients with hepatitis B virus infection: an analysis of National Health and Nutrition Examination Survey (NHANES) 1999-2018.","volume":"39","author":"Du","year":"2024","journal-title":"Prev Med Rep"},{"key":"R10-20260805","doi-asserted-by":"crossref","first-page":"e46305","DOI":"10.1097\/MD.0000000000046305","article-title":"Systemic immune-inflammation index as a predictor of all-cause mortality in patients with hepatitis B virus infection: a cross-sectional study based on NHANES 1999 to 2018.","volume":"104","author":"Chen","year":"2025","journal-title":"Medicine (Baltim)"},{"key":"R11-20260805","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12911-019-0918-5","article-title":"A data-driven approach to predicting diabetes and cardiovascular disease with machine learning.","volume":"19","author":"Dinh","year":"2019","journal-title":"BMC Med Inform Decis Mak"},{"key":"R12-20260805","doi-asserted-by":"crossref","first-page":"100118","DOI":"10.1016\/j.esmoop.2021.100118","article-title":"Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort.","volume":"6","author":"Fornarini","year":"2021","journal-title":"ESMO Open"},{"key":"R13-20260805","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1471-2407-13-158","article-title":"Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review.","volume":"13","author":"Jafri","year":"2013","journal-title":"BMC Cancer"},{"key":"R14-20260805","doi-asserted-by":"crossref","first-page":"100254","DOI":"10.1016\/j.esmoop.2021.100254","article-title":"Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer.","volume":"6","author":"Mountzios","year":"2021","journal-title":"ESMO Open"},{"key":"R15-20260805","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bbi.2023.10.002","article-title":"Combined influence of nutritional and inflammatory status and depressive symptoms on mortality among US cancer survivors: findings from the NHANES.","volume":"115","author":"Yao","year":"2024","journal-title":"Brain Behav Immun"},{"key":"R16-20260805","doi-asserted-by":"crossref","first-page":"1370322","DOI":"10.3389\/fpubh.2024.1370322","article-title":"Association between advanced lung cancer inflammation index and all-cause and cardiovascular mortality among stroke patients: NHANES, 1999-2018.","volume":"12","author":"Chen","year":"2024","journal-title":"Front Public Health"},{"key":"R17-20260805","doi-asserted-by":"crossref","first-page":"29693","DOI":"10.1038\/s41598-024-80983-1","article-title":"Associations of advanced lung cancer inflammation index with all-cause and respiratory disease mortality in adults with asthma: NHANES, 1999-2018.","volume":"14","author":"Fu","year":"2024","journal-title":"Sci Rep"},{"key":"R18-20260805","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/codi.15248","article-title":"The advanced lung cancer inflammation index predicts outcomes in patients with Crohn\u2019s disease after surgical resection.","volume":"23","author":"Kusunoki","year":"2021","journal-title":"Colorectal Dis"},{"key":"R19-20260805","doi-asserted-by":"crossref","first-page":"1397326","DOI":"10.3389\/fnut.2024.1397326","article-title":"Association of advanced lung cancer inflammation index with all-cause and cardiovascular mortality in US patients with rheumatoid arthritis.","volume":"11","author":"Ma","year":"2024","journal-title":"Front Nutr"},{"key":"R20-20260805","doi-asserted-by":"crossref","first-page":"934551","DOI":"10.3389\/fcvm.2022.934551","article-title":"The prognostic value of advanced lung cancer inflammation index (ALI) in elderly patients with heart failure.","volume":"9","author":"Yuan","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R21-20260805","doi-asserted-by":"crossref","first-page":"989914","DOI":"10.3389\/fnut.2022.989914","article-title":"The advanced lung cancer inflammation index predicts long-term outcomes in patients with hypertension: National health and nutrition examination study, 1999-2014.","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Nutr"},{"key":"R22-20260805","first-page":"434","article-title":"[ESPEN Practical Guideline: clinical nutrition in liver disease]. ESPEN: nutricion clinica en las enfermedades del higado.","volume":"39","author":"Bischoff","year":"2022","journal-title":"Nutr Hosp"},{"key":"R23-20260805","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nm.4275","article-title":"Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B.","volume":"23","author":"Fisicaro","year":"2017","journal-title":"Nat Med"},{"key":"R24-20260805","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s41043-025-00826-1","article-title":"Association between cardiac metabolic index and diabetic kidney disease: a cross-sectional study of NHANES 1999-2018.","volume":"44","author":"Zhang","year":"2025","journal-title":"J Health Popul Nutr"},{"key":"R25-20260805","doi-asserted-by":"crossref","first-page":"1493439","DOI":"10.3389\/fpubh.2024.1493439","article-title":"The neutrophil-lymphocyte ratio as a risk factor for all-cause mortality among individuals with resolved HBV infection: evidence from the NHANES 1999-2018.","volume":"12","author":"Qiu","year":"2024","journal-title":"Front Public Health"},{"key":"R26-20260805","doi-asserted-by":"crossref","first-page":"e23640","DOI":"10.1002\/jcla.23640","article-title":"Identification and external validation of the optimal FIB-4 and APRI thresholds for ruling in chronic hepatitis B related liver fibrosis in tertiary care settings.","volume":"35","author":"Liu","year":"2021","journal-title":"J Clin Lab Anal"},{"key":"R27-20260805","first-page":"1322","article-title":"Missing data in clinical research: a tutorial on multiple imputation.","volume":"37","author":"Austin","year":"2021","journal-title":"Can J Cardiol"},{"key":"R28-20260805","doi-asserted-by":"crossref","first-page":"625472","DOI":"10.3389\/fimmu.2021.625472","article-title":"The roles of neutrophils in the pathogenesis of liver diseases.","volume":"12","author":"Tang","year":"2021","journal-title":"Front Immunol"},{"key":"R29-20260805","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fimmu.2014.00258","article-title":"The role of natural killer cells and CD8(+) T cells in hepatitis B virus infection.","volume":"5","author":"Schuch","year":"2014","journal-title":"Front Immunol"},{"key":"R30-20260805","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.3390\/ijms23073636","article-title":"Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases.","volume":"23","author":"Buonacera","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R31-20260805","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/ijcp.12408","article-title":"Prognostic value of the neutrophil-to-lymphocyte ratio in patients with acute-on-chronic liver failure.","volume":"68","author":"Chen","year":"2014","journal-title":"Int J Clin Pract"},{"key":"R32-20260805","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/17520363.2024.2448112","article-title":"Predictive value of neutrophil-to-lymphocyte ratio and MELD score for short-term survival of patients with HBV-DeCi.","volume":"19","author":"Han","year":"2025","journal-title":"Biomark Med"},{"key":"R33-20260805","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1002\/hep.31836","article-title":"Albumin in advanced liver diseases: the good and bad of a drug!","volume":"74","author":"Jagdish","year":"2021","journal-title":"Hepatology"},{"key":"R34-20260805","doi-asserted-by":"crossref","first-page":"101161","DOI":"10.1016\/j.aohep.2023.101161","article-title":"Prognostic value of lactate\/albumin ratio in patients with acute-on-chronic liver failure.","volume":"28","author":"Golcuk","year":"2023","journal-title":"Ann Hepatol"},{"key":"R35-20260805","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.2147\/IJGM.S434572","article-title":"Predictive value of the prothrombin time-international normalized ratio to albumin ratio in the prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure.","volume":"16","author":"Sheng","year":"2023","journal-title":"Int J Gen Med"},{"key":"R36-20260805","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1186\/s12876-025-04201-6","article-title":"Association between serum albumin to creatinine ratio and non-alcoholic fatty liver disease: a longitudinal cohort study in non-obese Chinese individuals.","volume":"25","author":"Wu","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"R37-20260805","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1186\/s12876-025-04440-7","article-title":"The albumin-to-creatinine ratio predicts and explores potential mediation of mortality in metabolic dysfunction-associated steatotic liver disease in U.S. adults: evidence from NHANES 1999-2018.","volume":"25","author":"Zhou","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"R38-20260805","doi-asserted-by":"crossref","first-page":"649","DOI":"10.4254\/wjh.v15.i5.649","article-title":"Sarcopenia in chronic viral hepatitis: from concept to clinical relevance.","volume":"15","author":"Coelho","year":"2023","journal-title":"World J Hepatol"},{"key":"R39-20260805","doi-asserted-by":"crossref","first-page":"253","DOI":"10.14309\/ajg.0000000000001575","article-title":"Hepatitis B virus infection and extra-hepatic manifestations: a systemic disease.","volume":"117","author":"Cacoub","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"R40-20260805","doi-asserted-by":"crossref","first-page":"1237618","DOI":"10.3389\/fendo.2023.1237618","article-title":"Association between resolved hepatitis B virus infection and femoral and spinal bone mineral density in American adults: a cross-sectional study.","volume":"14","author":"Yang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048403","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T16:01:19Z","timestamp":1785945679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":40,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048403","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"2026-01-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}